Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD)

Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD)

US Patent 12310949 · Granted May 27, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monohydrate potassium salt of a thienopyridone derivative and its preparation pr2025
Monohydrate potassium salt of a thienopyridone derivative and its preparation pr2025
Methods of treating subjects having diabetes with chronic kidney disease2024
Methods of treating subjects having diabetes with chronic kidney disease2024
Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or a2023
Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or a2023
Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or a2023
Film-coated tablet comprising a triazine derivative for use in the treatment of 2023
Methods of synthesizing enantiopure deuterium-enriched pioglitazone2023
Methods of treating heart failure with preserved ejection fraction2023
Crystalline forms of deuterium-enriched pioglitazone2022
Methods of treating subjects having diabetes with chronic kidney disease2022